Moreover, when TG2 is secreted by pancreatic cancer cells, it can activate cancer-associated fibroblasts to produce laminin A1 which, in turn, shields tumor cells from gemcitabine-induced cell cytotoxicity by triggering signaling pathways, such as the FAK pathway [59,110]. This evidence concerns the gene TGM2 and pancreatic neoplasm.